CLINICAL AND IMMUNOBIOCHEMICAL MARKERS IN THE DIAGNOSIS OF BRONCHIAL ASTHMA COMBINED WITH TYPE 2 DIABETES MELLITUS

Faizullaeva N. Ya.; Mukhtorov Sh. M.; Raufov A. A.; Nabieva U. P.; Yarmukhammedov A. S.

CLINICAL AND IMMUNOBIOCHEMICAL MARKERS IN THE DIAGNOSIS OF BRONCHIAL ASTHMA COMBINED WITH TYPE 2 DIABETES MELLITUS

Authors

Faizullaeva N. Ya.
Mukhtorov Sh. M.
Raufov A. A.
Nabieva U. P.
Yarmukhammedov A. S. Institute of Human Immunology and Genomics of the Academy of Sciences of the Republic of Uzbekistan

Keywords:

Bronchial asthma, type 2 diabetes mellitus, immunobiochemical markers, superoxide dismutase, tPA, PAI-1, diagnostics.

Abstract

The aim of the study was to investigate clinical, laboratory and immunobiochemical markers in patients with bronchial asthma (BA) combined with type 2 diabetes mellitus (T2DM). A comparative analysis of clinical manifestations, carbohydrate metabolism parameters, fibrinolysis and the antioxidant system was performed.

Downloads

Published

2025-11-13

Issue

Vol. 3 No. 11 (2025): WOSS

Section

Articles

License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

How to Cite

CLINICAL AND IMMUNOBIOCHEMICAL MARKERS IN THE DIAGNOSIS OF BRONCHIAL ASTHMA COMBINED WITH TYPE 2 DIABETES MELLITUS. (2025). Web of Scientists and Scholars: Journal of Multidisciplinary Research, 3(11), 6-16. https://webofjournals.com/index.php/12/article/view/5384